Response to: Correspondence on 'Current myositis clinical trials and tribulations' by Saygin et al

被引：0
|
作者：
Saygin, Didem [1 ,8 ]
Werth, Victoria [2 ]
Paik, Julie J. [3 ]
Park, Jin Kyun [4 ]
Needham, Merrilee [5 ,6 ]
Lundberg, Ingrid E. [6 ]
Christopher-Stine, Lisa [7 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Dept Med, Div Rheumatol, Pittsburgh, PA USA
[2] Univ Penn, Dept Dermatol, Philadelphia, PA USA
[3] Johns Hopkins Univ, Rheumatol, Baltimore, MD USA
[4] Seoul Natl Univ Hosp, Rheumatol, Seoul, South Korea
[5] IIID Murdoch Univ, Dept Neurol, Perth, WA, Australia
[6] Univ Notre Dame, Perth, WA, Australia
[7] Johns Hopkins Univ, Med Rheumatol, Baltimore, MD USA
[8] Univ Pittsburgh, Med Ctr, Dept Med, Pittburgh, PA 15260 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2024年
关键词：
Dermatomyositis; Polymyositis; Outcome Assessment; Health Care;
D O I：
10.1136/ard-2024-225762
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] FLASH Clinical Trials In Regard to Buchsbaum et al Reply
    Deek, Matthew P.
    Stish, Bradley J.
    Tran, Phuoc T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (05): : 1547 - 1548
  • [32] Esketamine clinical trials: reply to Maju et al.
    Gastaldon, C.
    Papola, D.
    Ostuzzi, G.
    Barbui, C.
    EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2020, 29
  • [33] Response to: 'Detection of myositis-specific antibodies: additional notes' by Infantino et al
    Tjarnlund, Anna
    Lundberg, Ingrid E.
    Ronnelid, Johan
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (04)
  • [34] The Reporting of Confidence Intervals in Exploratory Clinical Trials and Professional Insecurity A Response to Ritchie et al.
    Turkington, Douglas
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2014, 202 (07) : 567 - 567
  • [35] Should weakness be subsumed to nonspecific complaints?-Correspondence in response to Bhalla et al
    Nickel, C. H.
    Malinovska, A.
    Bingisser, R.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2015, 33 (05): : 722 - 723
  • [36] Response to: 'Correspondence on 'Statistical review: frequently given comments'' by Waki et al
    Lydersen, Stian
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (06) : E129 - +
  • [37] Response to correspondence from Dr S. Papapetropoloulos et al.
    Kamakura, K
    Mochizuki, H
    Kaida, K
    Hirata, A
    Masaki, T
    Nakamura, R
    PARKINSONISM & RELATED DISORDERS, 2005, 11 (04) : 267 - 267
  • [38] The unblinding of statisticians in clinical trials: commentary on Iflaifel et al., Trials 2023
    Parker, Richard A.
    TRIALS, 2023, 24 (01)
  • [39] The unblinding of statisticians in clinical trials: commentary on Iflaifel et al., Trials 2023
    Richard A. Parker
    Trials, 24
  • [40] Response to: Correspondence on 'Demographic, exposure and clinical characteristics in a multinational registry of engineered stone workers with silicosis' by Hoy et al
    Hua, Jeremy Tang
    Zell-Baran, Lauren
    Go, Leonard H. T.
    Kramer, Mordechai R.
    Van Bree, Johanna B.
    Chambers, Daniel
    Newbigin, Katrina
    Deller, David
    Matula, Michael
    Fireman, Elizabeth
    Dahbash, Mor
    Martinez-Gonzalez, Cristina
    Leon-Jimenez, Antonio
    Sack, Coralynn
    Ferrer Sancho, Jaume
    Villar, Ana
    Almberg, Kirsten S.
    Cohen, Robert A.
    Rose, Cecile S.
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2022, 79 (12) : 849 - 850
12345